CLASS II Drug recall · Reported 23 Oct 2024 · FDA Enforcement Report

Cisplatin Injection, 100mg/ (1mg/mL) recalled by Accord Healthcare

Accord Healthcare is recalling Cisplatin Injection, 100mg/ (1mg/mL), For Intravenous Use Multiple Dose Vial, distributed nationwide in the US. The recall was initiated on 1 Oct 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: P2202009, Exp. Date: 03/2025
NDC16729-288
UPC0316729288385, 0316729288118
Quantity recalled11,214 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0010-2025
FDA event ID
95455
Recalling firm
Accord Healthcare, Raleigh, NC
Manufacturer
Accord Healthcare Inc.
Classification
Class II
Status
Terminated
Recall initiated
1 Oct 2024
FDA classified
11 Oct 2024
Reported
23 Oct 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

1 Oct 2024Recall initiated by company
11 Oct 2024Classified by FDA+10 days
23 Oct 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38

Where it was distributed

Nationwide within the United States and PR

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications.

Which lots are affected?

Lot #: P2202009, Exp. Date: 03/2025

Where was it sold?

Nationwide within the United States and PR

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Accord Healthcare

All 106

Other Cisplatin recalls

All 4